Background The McDonald criteria were introduced in 2001 as guidelines to facilitate early and accurate diagnosis of multiple sclerosis (MS). They were revised in 2005. Although validated in a number of research-focused clinical centres, their adequacy and utility in the general neurology setting is less certain.
Objective In this study, we assessed new diagnoses of MS in our practice for compliance with both the original and the revised criteria.
Methods We retrospectively identified new diagnoses of MS from 2001. Clinical notes and imaging were evaluated for compliance with McDonald criteria.
Results Sixty-two patients were included: 53 with `practice-definite' and nine with `practice-possible' diagnoses of MS. At the time of diagnosis, 47% of the `practice-definite' group fulfilled the 2001 criteria and 49% the revised criteria. Among patients not satisfying the criteria at time of diagnosis, 21% went on to fulfil the McDonald criteria over the 23-month follow-up.
Conclusions There is a considerable gap between the clinical diagnosis of MS in a general neurology setting and compliance with the McDonald criteria. Failure to perform follow-up MRI on patients with clinically isolated syndromes is a sizeable factor in this diagnostic-gap and needs to be improved. In this setting, practical differences between the original and revised criteria appear to be small.
McDonald WI, Compston A., Edan G., Goodkin D., Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50(1): 121—7.
2.
Polman CH, Reingold SC, Edan G., Filippi M., Hartung HP, Kappos L. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58(6): 840—6.
3.
Dalton CM, Brex PA, Miszkiel KA, Hickman SJ, MacManus DG, Plant GT et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol2002; 52(1): 47—53.
4.
CHAMPS study group.MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology2002; 59: 998—1005.
5.
Korteweg T., Tintore M., Uitdehaag B., Rovira A., Frederiksen J., Miller D. et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol2006; 5: 221—7.
6.
Swanton JK, Fernando K., Dalton CM, Miszkiel KA, Thompson AJ, Plant GT et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry2006; 77: 830—3.
7.
Comi G., Filippi M., Barkhof F., Durelli L., Edan G., Fernandez O. et al. Effect of early interferon treatment on conversion to definite multiple sclerosis. Lancet2001; 357: 1576—82.
8.
Brex PA, Ciccarelli O., O'Riordan JI, Sialer M., Thompson AJ, Miller DHA longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med2002;346: 158—64.
